Company intelligence / Profile preview

Hayfin Capital Management

London, United Kingdom

Ownership: Private
Employees: ~90
Development stage: Other

Overview

Hayfin Capital Management is a leading global credit fund manager focused on investments across healthcare, biotech, pharma, medical devices, and related sectors. It does not invent, develop, or commercialize drugs or medtech itself, but serves as an investor providing financing and growth capital solutions to companies in these industries[4][8].

Industry: Investors

Partnerships

Impilo (co-lead investor for Immedica Pharma)[5][9]21 Invest France (lead investor for ProductLife Group)[6]MolecuLight (lead healthcare institutional investor)[1][2][3]

Beyond the preview

Go deeper on Hayfin Capital Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hayfin Capital Management.

Explore the full profile